← Eichor
Study identifier: NCT06081010 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

FCHV-HTN Implementation Trial in Nepal

Condition: Hypertension  ·  Sponsor: Yale University

PhaseNA
Planned participants3572
Who can joinAll sexes, 30 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this hybrid type III study incorporating a cluster-randomized trial is to assess the effect of a community health worker-led hypertension prevention and control program (CHPC) on the implementation outcomes and clinical outcomes among patient with hypertension in central Nepal. The main questions it aims to answer are: 1\. What is the level of implementation outcomes, including reach, adoption, implementation fidelity, and maintenance of the CHPC implementation strategy at the patient, provider, and health system levels? 2: What is the effectiveness of the CHPC implementation strategy compared to facility-based intervention on systolic BP via a cluster randomized controlled trial. 3: What is the implementation cost and cost-effectiveness of the CHPC implementation strategy? Participants will receive four follow-up group meetings or home visits every three months for a year by a community health worker. Researchers will compare if there is a significant difference in systolic blood pressure between those who receive this intervention and those who do not receive the intervention in the same community.

This description comes directly from the study's public registry record.

Talk to the study team

Donna Spiegelman, ScD  ·  6178355119  ·  donna.spiegelman@yale.edu

Eleni Mersiadis  ·  eleni.mersiadis@yale.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Dhulikhel HospitalDhulikhel, NepalRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06081010